Spectris has gone mobile. The injector of MRI contrast media has been adapted by Medrad for use in the tight quarters of MRI trailers. This configuration has a space-saving base-plate that secures the injector to the wall and a transportation clamp that
Spectris has gone mobile. The injector of MRI contrast media has been adapted by Medrad for use in the tight quarters of MRI trailers. This configuration has a space-saving base-plate that secures the injector to the wall and a transportation clamp that also secures the injector head to the wall for easy and safe transport. It is compatible with the four major mobile trailer manufacturers: Calumet Coach, Medical Coaches, AK Associates, and Ellis & Watts. The mobile configuration is currently available in North America and will roll out in Europe, Latin America, and Japan at a later date.
© 2001 Miller Freeman Inc.
3/28/01, Issue # 1506, page 6.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.